Learn More
PURPOSE The aim of this prospective study was to evaluate whether [¹⁸F]FDG-PET/CT, performed within two weeks of starting erlotinib therapy can predict tumor response defined by RECIST 1.1 criteria after 8 weeks of treatment in patients with inoperable (stage IIIA to IV) non-small cell lung cancer patients. PATIENTS AND METHODS Three [¹⁸F]FDG-PET/CT scans(More)
INTRODUCTION This randomized phase II study investigated the efficacy and safety of a new taxane, larotaxel (XRP9881), in combination with either cisplatin or gemcitabine in the first-line treatment of patients with nonirradiable stage IIIB or stage IV non-small cell lung cancer to select the combination having the most promising antitumor activity. (More)
Rare type of division of the median nerve in proximal 1/3 of the forearm was described. The finding was made during autopsy of 53 years old white man. A nerve branch that run separately from the main trunk of the median nerve appeared to be the common digital nerve to the 3rd and 4th finger. Between this branch and the main trunk the radial head of the(More)
  • 1